Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sinohealth Holdings Ltd. ( (HK:2361) ) has issued an update.
Sinohealth Holdings Limited reported a 7.3% decrease in revenue for the first half of 2025, attributed to strategic business restructuring and a shift in profit models. Despite the revenue decline, the company saw a significant increase in its in-hospital business contracts and client base, reflecting its focus on long-term growth and technological upgrades. The company continues to strengthen its market position by expanding its ecosystem and industry network, aiming for high-quality development amid a challenging pharmaceutical market landscape.
More about Sinohealth Holdings Ltd.
Sinohealth Holdings Limited, incorporated in the Cayman Islands, is a leader in medical and health data technology in China. The company leverages its extensive experience in the health industry to provide AI-driven digital and intelligent solutions across various sectors, including medical care, pharmacies, commercial use, health management, and R&D.
Average Trading Volume: 7,558
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.43B
Learn more about 2361 stock on TipRanks’ Stock Analysis page.